Is HCP Plastene overvalued or undervalued?

As of 20 June 2025, the valuation grade for HCP Plastene has moved from attractive to very attractive, indicating a strong improvement in its perceived value. The company is currently considered undervalued, with a PE ratio of 18.95, an EV to EBITDA ratio of 10.48, and a PEG ratio of 0.02, which suggests significant growth potential relative to its price.
In comparison to peers, HCP Plastene's valuation metrics stand out; for instance, Garware Hi Tech has a PE ratio of 28.07 and an EV to EBITDA of 19.64, categorizing it as very expensive, while AGI Greenpac, also very attractive, has a PE ratio of 15.64 and an EV to EBITDA of 8.47. The company's recent stock performance has been mixed, with a year-to-date return of 10.13%, outperforming the Sensex's 5.46% in the same period, but it has underperformed over the longer term. Overall, HCP Plastene appears to be a compelling investment opportunity within the packaging industry.